Continuous Glucose Monitoring Powered by Eclipse

 

14 Days Real-Time CGM

GlucoRx AiDEX™ CGM constantly measures and records glucose levels every 5 minutes, 24 hours a day

 

  • Real Time Notifications

  • Readings Every 5 Minutes

  • Smart Device Connectivity

Why choose GlucoRx AiDEX™ CGM?

  • Improved glycaemic control

    Track and control sugar levels with dynamic glucose information every 5 minutes, all through the day and night. See trends in real time to act earlier when sugar levels are starting to rise or drop. Help improve HbA1c level as insulin doses are tailored more carefully.

  • Enhanced quality of life

    Eliminate finger sticks while making diabetes management decisions easier. Decrease manual keeping. Set alarms on GlucoRx AiDEX™ when glucose levels rise or fall a certain amount so changes can be made quickly to treat or prevent highs or lows. Remote viewing of data, shared with family and clinicians with consent.

  • Increased self-management

    Fill in gaps for a better understanding of glycaemic patterns, allowing personalised care. Increase insight regarding food, portions, physical activity, stress, weight management and diabetes medication choices from their impact on glucose levels. Improve health and prevent complications of diabetes with good glucose management.

Accuracy

GlucoRx AiDEX™ has an overall system accuracy of 98.69% and overall MARD result of 9.08% when compared to the venous blood glucose reference.

View the full study online here.

Fully Integrated With

 24 million patients that have an active Eclipse portal. Supporting at risk patients through integrated technological enabled care services. The Connect service enables:

  1. Identification of patients that would benefit from integrated technological enabled care services by:

  2. Engagement with those patients who have expressed interest

  3. Implantation, data integration and hub support for patients

  4. Generation of Alerts and support management plans linked to outputs.

  5. Validation of impact including equality of care analysis of the CONNECT programme.

 
 
 

  • Step 1: Identification of Patients

    The system undertakes a Gap Analysis to identify missing information or that would benefit from solution. It also enables prioritisation of patients through standardised criteria. Patients from vulnerable cohorts and lower socio-economic locations can be identified to enable appropriate support implementations. This enables effective use of healthcare workers to focus on those individuals with the greatest need.

  • Step 2: Patient Review

    Standardised centralised patient review capability.

  • Step 3: Patient Engagement

    Our award winning patient engagement programme enables appropriate prioritisation and effective communication with patients, improving health outcomes whilst reducing workload for health and social care services.

  • Step 4: Remote Device Telehealth

    Utilising our extensive range for remote telehealth devices detailed metrics can be monitored remotely.

  • Step 5: Dynamic Alerts

    Stratification Alerts utilising established national best practice guidance; UKMI Primary Care Drug Monitoring Guidelines and relevant NICE Recommendations. The resulting suite of alerts are integral to the only NHS Digital centrally assured and centrally funded risk stratification tool.

  • Step 6 - Effective Outcomes & Equality of Care

    Our service guarantees to improve your healthcare and equality targets for your chosen clinical pathways. Longitudinal tracking of live data enables monthly updates to be provided for key stakeholders within the project. Our VISTA outcome system is widely regarded as the best outcome analytics platform in healthcare.

 

GlucoRx AiDEX™ HUB

Get upskilled on this CGM from various training resources

 

For Patients

For Healthcare Professionals

 

Reports

Click here to get full analysis reports on GlucoRx AiDEX™ glucose results

 

For Patients

  • CGM Readings

  • Stats

  • Time In Range

  • Share With Professionals

For Healthcare Professionals

  • Patient List

  • Adding New Patients

NICE have updated their guidelines to recommend CGM devices to people living with diabetes.

They write:

New guidance from NICE has recommended the use of real-time continuous glucose monitoring (rtCGM) for adults and children living with type 1 diabetes for the first time. It will give them a continuous stream of real-time information on a smartphone about their current blood glucose level.

Alongside new rtCGM technology, the use of intermittently scanned glucose monitoring (isCGM) devices – also known as flash monitoring – has been expanded to the whole of the type 1 patient population. Patients will now have a choice in picking the technology which is right for them in discussion with their diabetes team.

NHS England has rolled out NICE recommended flash devices to around 50% of those with type 1 diabetes.

NICE has recommended extending the use of flash monitoring to adults with type 2 diabetes on insulin therapy. This recommendation makes the technology available to around 193,000 people.


“By recommending the use of either real-time or flash monitoring, our independent committee has made recommendations that will be a step forward in helping all people with type 1 diabetes manage their condition.

“Many people find finger-prick testing to be painful and time consuming and the introduction of technology for all people living with type 1 diabetes will reduce this considerably. This group of people also live with the constant worry of suffering from an attack brought on by dangerously low blood sugar while they sleep. Having an alarm which will alert them if this happens will give them the peace of mind knowing they will wake up in the morning.”

— Dr Paul Chrisp, director of the centre for guidelines at NICE

 

Read full article here.

“These landmark guidelines promise to be transformational for people living with diabetes. Having campaigned for many years for wider access to Flash and continuous glucose monitoring, and contributed to NICE’s consultation, we are delighted that the voice of people with diabetes has been heard, and that our calls have been listened to.

“What we are seeing today is a key shift in thinking – a move to recognising that technology is an integral part of diabetes management, not simply an added luxury.”

— Chris Askew OBE, chief executive at Diabetes UK

Head Office:

GlucoRx Ltd, Unit 1C Henley Business Park, Pirbright Road, Guildford, Surrey, GU3 2DX

E-mail: info@glucorx.co.uk

Tel: 0800 007 5892

Website: www.glucorx.co.uk